iShares Biotechnology ETF (NASDAQ:IBB) Holdings Raised by Appleton Partners Inc. MA

Appleton Partners Inc. MA increased its stake in iShares Biotechnology ETF (NASDAQ:IBBFree Report) by 1.2% during the first quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 72,932 shares of the financial services provider’s stock after purchasing an additional 870 shares during the quarter. Appleton Partners Inc. MA owned approximately 0.13% of iShares Biotechnology ETF worth $10,008,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other institutional investors have also recently bought and sold shares of the stock. B. Riley Wealth Advisors Inc. lifted its holdings in shares of iShares Biotechnology ETF by 19.8% in the fourth quarter. B. Riley Wealth Advisors Inc. now owns 13,768 shares of the financial services provider’s stock valued at $1,870,000 after purchasing an additional 2,275 shares in the last quarter. Leo Wealth LLC purchased a new stake in iShares Biotechnology ETF in the 4th quarter worth about $319,000. Objective Capital Management LLC boosted its position in iShares Biotechnology ETF by 30.1% during the 4th quarter. Objective Capital Management LLC now owns 2,808 shares of the financial services provider’s stock worth $382,000 after acquiring an additional 650 shares during the period. Gerber LLC purchased a new position in iShares Biotechnology ETF during the 4th quarter valued at about $274,000. Finally, Twin Focus Capital Partners LLC increased its holdings in shares of iShares Biotechnology ETF by 110.1% in the 4th quarter. Twin Focus Capital Partners LLC now owns 10,542 shares of the financial services provider’s stock valued at $1,432,000 after purchasing an additional 5,524 shares during the period. Hedge funds and other institutional investors own 62.45% of the company’s stock.

iShares Biotechnology ETF Price Performance

Shares of NASDAQ IBB traded down $0.51 during mid-day trading on Tuesday, reaching $134.93. The company had a trading volume of 310,063 shares, compared to its average volume of 1,659,797. The stock has a fifty day moving average of $132.89 and a two-hundred day moving average of $134.13. iShares Biotechnology ETF has a 12-month low of $111.83 and a 12-month high of $141.16.

iShares Biotechnology ETF Dividend Announcement

The business also recently announced a quarterly dividend, which was paid on Wednesday, March 27th. Shareholders of record on Friday, March 22nd were paid a dividend of $0.126 per share. This represents a $0.50 dividend on an annualized basis and a dividend yield of 0.37%. The ex-dividend date of this dividend was Thursday, March 21st.

About iShares Biotechnology ETF

(Free Report)

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.

Featured Stories

Want to see what other hedge funds are holding IBB? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for iShares Biotechnology ETF (NASDAQ:IBBFree Report).

Institutional Ownership by Quarter for iShares Biotechnology ETF (NASDAQ:IBB)

Receive News & Ratings for iShares Biotechnology ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for iShares Biotechnology ETF and related companies with MarketBeat.com's FREE daily email newsletter.